Welcome to our dedicated page for Carecloud news (Ticker: CCLD), a resource for investors and traders seeking the latest updates and insights on Carecloud stock.
CareCloud, Inc. (Nasdaq: CCLD) generates frequent news as a healthcare technology company focused on AI-powered and technology-enabled solutions for medical practices, hospitals, and health systems. Its announcements highlight developments in revenue cycle management (RCM), electronic health records (EHR), practice management (PM), analytics, patient experience management (PXM), digital health, and artificial intelligence (AI).
News coverage for CareCloud often features product launches and AI initiatives. Recent examples include the full launch of stratusAI Desk Agent, an agentic AI phone receptionist designed to automate patient phone interactions and integrate with EHR and PM systems, and updates on stratusAI Voice Audit, a conversational intelligence platform that analyzes patient calls and provides performance metrics and insights.
Investors and healthcare professionals can also follow acquisition and partnership announcements. CareCloud has reported acquiring Medsphere Systems Corporation, bringing the Wellsoft emergency department information system into its portfolio, and entering into an agreement to acquire HFMA’s MAP App, a hospital benchmarking tool for revenue cycle performance, supported by a long-term joint marketing partnership with the Healthcare Financial Management Association.
Another major category of news involves financial results, guidance, and capital structure updates. CareCloud issues quarterly earnings releases, updates revenue guidance, and discusses profitability, cash flow, and the impact of acquisitions. The company also publishes information on preferred stock dividends, including its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock (CCLDO) and plans to address accumulated dividends through structured payment programs.
Governance and regulatory updates, such as SEC filings describing material events, board composition changes, and Nasdaq listing rule compliance matters, appear in the news flow as well. For ongoing insight into how CareCloud is evolving its AI strategy, expanding in the hospital IT market, and managing its financial profile, readers can use this page as a centralized feed of company press releases and related coverage.
CareCloud (Nasdaq: CCLD), a provider of AI-powered healthcare technology and revenue cycle management solutions, has scheduled its Q2 2025 earnings release for August 5, 2025, before market opening.
The company will host a conference call for investors at 8:30 a.m. Eastern Time on the same day. Investors can access the live webcast and presentation slides at ir.carecloud.com/events, or join via audio-only option by dialing 201-389-0920.
CareCloud (Nasdaq: CCLD), a healthcare technology and revenue cycle management solutions provider, reported a remarkable 70% stock price increase in Q2 2025, emerging as one of the top gainers in the Russell Microcap® Index. The company was officially added to the index on June 30, 2025.
Key developments include the launch of an AI Center of Excellence, resumed M&A activities, conversion of 3.5 million Series A Preferred shares into Common Stock, and a healthy cash position of over $10 million. The company's strategic focus on AI innovation and intelligent health solutions positions it for continued growth in 2025.
CareCloud (Nasdaq: CCLD), an AI-driven healthcare technology solutions provider, has been added to the Russell Microcap® Index effective June 30, 2025. The company experienced significant growth with its stock price rising approximately 70% during Q2 2025.
Notable achievements include launching an AI Center of Excellence, resuming acquisition activities, and maintaining a strong cash position of $10 million at Q2 end. Additionally, approximately 3.5 million shares of Series A Preferred Stock were converted to Common Stock on March 6, 2025.
CareCloud (Nasdaq: CCLD), an AI-driven healthcare technology solutions provider, has announced reaching a significant milestone with a public float of $85.1 million as of June 30, 2025. This achievement triggers new SEC compliance requirements, specifically the need for auditor attestation of Internal Control over Financial Reporting (ICFR) under Sarbanes-Oxley Act Section 404(b).
The Company's current audit firm has indicated it lacks capacity to perform the required ICFR attestation. As SEC regulations mandate the same firm conduct both financial statement audit and ICFR attestation, CareCloud has initiated a search for a new audit firm to handle these responsibilities for fiscal year 2025.
CareCloud (Nasdaq: CCLD), an AI-driven healthcare technology solutions provider, announced that its current independent registered public accounting firm may resign if the company requires an Internal Control over Financial Reporting (ICFR) attestation for fiscal year 2025.
The requirement for ICFR attestation will be determined by CareCloud's public float as of June 30, 2025. If it reaches or exceeds $75 million, the company will be classified as an accelerated filer, necessitating the attestation under Section 404(b) of the Sarbanes-Oxley Act. The current audit firm has stated it lacks capacity for ICFR attestation, which would require CareCloud to engage a new accounting firm as SEC rules mandate the same firm conduct both financial statement audit and ICFR attestation.
CareCloud (NASDAQ: CCLD) held its 2025 Annual Shareholders' Meeting on May 27, 2025, where shareholders approved three key proposals. The meeting resulted in the re-election of three board members - Anne Busquet, Bill Korn, and Lawrence Sharnak - for two-year terms. Shareholders also approved the compensation package for named executive officers and the appointment of Rosenberg Rich Baker Berman, P.A. as the company's independent registered public accounting firm for the fiscal year 2025.
The re-elected board members bring significant experience: Busquet has over 30 years of executive experience with American Express and Interactive Corp, Korn previously served as CareCloud's CFO for 10 years until October 2023, and Sharnak held various senior leadership roles during his 30-year tenure at American Express.
CareCloud (NASDAQ: CCLD) has been named the "Top Healthcare IT Pick for 2025" by Maxim Group, highlighting the company's AI strategy and strong financial performance. Maxim Group's analyst Allen Klee emphasized CareCloud's attractive valuation, noting it trades at a 2026 EV/EBITDA multiple of 5.0x, significantly below the peer group average of 12.5x.
The company reported impressive Q1 2025 results with 52% year-over-year adjusted EBITDA growth. CareCloud's recently launched AI Center of Excellence, starting with 50 AI professionals and planning to expand to 500 by year-end, demonstrates its commitment to AI integration. The company's AI suite includes tools like cirrusAI Notes, cirrusAI Appeals, and cirrusAI Voice, positioning CareCloud as a leader in healthcare AI solutions.
CareCloud (CCLD) has announced monthly cash dividend payments for its Series A and Series B Preferred Stock for May and June 2025. Both series carry an 8.75% annual dividend rate on a $25.00 per share liquidation preference. The monthly dividend for both series is set at $0.18229 per share. Series A holders will receive an additional payment of $0.04688 per share, reflecting a 2.25% adjustment from a previous 11% dividend rate. The dividends will be paid on June 16, 2025, and July 15, 2025, with respective record dates of May 31 and June 30, 2025.